• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

A Winning Value Portfolio Update

Despite underperforming so far, the portfolio is well undervalued.
By SHAM GAD Mar 03, 2015 | 01:00 PM EST
Stocks quotes in this article: BAC, CHK, GM, PKX, WFM, KIN, SZMK, LNG, TZOO, MUR

While monthly performance numbers are completely irrelevant in my opinion, the Gad Winning Value Portfolio demonstrated why buying undervalued securities over the long-run is likely to be a market-beating strategy.

At the end of February, the results stacked up like this:

As of Feb. 27, 2015, the class of 2015 was up 0.4% against an advance of 2.5% for both the S&P 500 and Wilshire 5000. However, I'm not too concerned about the trailing performance against the market index thus far, as I believe the portfolio of 10 securities is well undervalued.  

That element of undervaluation surfaced in February when Sizmek (SZMK) reported strong quarterly results. The shares were down 2% at the end of January, before the company's strong operating performance propelled the shares up 26% during the month of February. This further affirms to me that when an undervalued security is purchased and given time, quality operating performance has an extraordinary effect on equity returns.

The opposite is also true, however, which further illustrates why value investing works. If you buy an "optimistically" valued business and it delivers mediocre results, or good results that aren't as exciting as hoped, equity value can be lost very quickly.

Overall, I expect energy prices will have a significant effect on the portfolio's overall return, seeing as how we have two names, Chesapeake Energy (CHK) and Murphy Oil (MUR) that benefit from a rising oil price. That being said, CHK and MUR were chosen because of either significant assets or a low-cost structure that would make them more resilient in a new oil price environment. Cheniere Energy (LNG), on the other hand, should do well in any energy pricing environment.

But low energy prices are a tailwind for automakers and our GM warrants (GM-WTB) are up 12% year to date. Meanwhile, Travelzoo (TZOO), while still down 20% year to date, got some attention as a result of consolidation elsewhere in the online travel industry. Some interesting things can happen in this space during the course of the year.

This portfolio, in particular, has various positions that are likely to do incredibly well in the event of certain catalysts but were also bought at prices which should lead to little to no permanent loss of capital over a period of a year or more. Stay tuned.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline on this article.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Gad was long KIN, WFM, LNG, SZMK, and PKX.

TAGS: Investing | U.S. Equity

More from Investing

Don't Shout 'V' for Victory, Yet

James "Rev Shark" DePorre
Jun 27, 2022 4:22 PM EDT

Even after last week's move higher and Monday's narrow range of movement, we can say it's going to be difficult to produce a 'V'-shaped setup like we had at the pandemic low in 2020.

Let's See If Vertex Pharmaceuticals Can Push Higher on the Charts

Bruce Kamich
Jun 27, 2022 3:03 PM EDT

Here's what traders should do.

LyondellBasell Could Hold Temporarily Before Renewed Declines

Bruce Kamich
Jun 27, 2022 2:22 PM EDT

Let's take a look.

Kass: Why Markets Could Make a Yankees-Like Comeback

Doug Kass
Jun 27, 2022 2:00 PM EDT

I remain uncharacteristically bullish. Here's why.

Here's How to Treat Bristol-Myers Squibb's Charts

Bruce Kamich
Jun 27, 2022 1:10 PM EDT

BMY is breaking out to a new high.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 12:04 AM EDT PAUL PRICE

    Two Good Signs -- Especially for Small-Cap Investors

  • 12:10 AM EDT PAUL PRICE

    More Insider Buying in American Woodmark (AMWD)

    American Woodmark , which I've discussed here fr...
  • 08:55 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    The 10 personality traits of successful traders an...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login